Atlas Trials

A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone

Clinical trial NCT01979679 · COMPLETED

Trial details

NCT number
NCT01979679
Sponsor
University of California, Irvine
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2008-12-01
Primary completion
2013-10-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.